Medical Cyclotron Market Size & Forecast Report, 2014 - 2025

The Medical Cyclotron Market was appreciated by US$ 118.2 million in the year 2016. It is estimated to develop at the CAGR of 10.9% by the completion of the prediction period. Growing occurrence of cancer, increasing preference towards nuclear-powered images for precise judgment, price benefit as equated to subcontracted emitting radiation tracers, and obtainability of technically innovative analytical devices are between important tendencies activating the progress of the market.

Radiotherapy is one of the technically progressive procedures utilized in the analysis and action of tumorous cells. As stated by the World Nuclear Association, nearly 40 million processes are carried out, every year, by means of nuclear medications, by yearly development of 5%. The medical cyclotron market on the source of Type of Product could span Cyclotron 24 MeV & Above, Cyclotron 19-24 MeV, Cyclotron 16-18 MeV, Cyclotron 10-12 MeV.

The medical cyclotron market on the source of Area with respect to Trades in terms of intake, Profits, Market stake, and Development percentage could span North America [U.S., Canada], Latin America [Brazil, Mexico], Europe [Germany, U.K.], Asia Pacific [Japan, Australia], Middle East & Africa [South Africa].

By the source of geography, Asia Pacific was responsible for the uppermost stake in the market during the year 2016. The area is projected to preserve its supremacy all through the prediction period, due to increasing demand for nuclear images and the spreading base of cancer patients. In addition to this, growing funds in healthcare substructure, closure of nuclear devices, and increasing demand for economic choices are paying to the development of the provincial market.

In or after 2016, Japan was in the front position of the Asia Pacific’s market. The nation will carry on to the foremost income supplier by means of a stake of around 77.0% by the year 2025. Owing to the easy obtainability of radioactive tracers, the amount of nuclear images is expected to grow in this area during the prediction period. Japan locked its last nuclear reactor at Tomari nuclear plant, during the year 2012. This nuclear plant was the basis of radioactive isotopes, utilized such as radioactive tracers in medicinal analysis. Therefore, Japan observed the setting up of the maximum number of new-fangled particle accelerators and is composed to set up 49 novel accelerators by 2025.

By way of greater demand for medical cyclotrons in the area of Asia Pacific, the market is expected to observe a CAGR of 11.6% by means of income above the period of prediction. The market in Europe is estimated to display a CAGR of 11.1% above the period of prediction. Europe is expected to grasp the subsequent major stake by capacity during the course of the prediction period. The area will keep on a protuberant destination for the companies operating due to the greater occurrence of cancer, growing cancer analytic processes, and increasing alertness about nuclear images.

The statement revises Trades in terms of intake of medical cyclotron in the market; particularly in North America, Europe, Asia Pacific, Latin America, Middle East & Africa. It concentrates on the topmost companies operating in these regions. Industrialists face greater barricades for the entry of the market and stringent controlling obedience together with the greater operational price for manufacturing these machines. Thus, there are merely a small number of companies that constitute a superior market stake.

Yet, more or fewer companies for example TeamBest are evolving an inventive product by way of the capability of 400 MeV for particle therapy through weighty ions. These are likely to deliver additional precise analysis and action of cancer. Some of the important companies operating in the medical cyclotron on a global basis are TeamBest [Best Medical, Inc.], Advanced Cyclotron Systems, GE Healthcare, Sumitomo Heavy Industries, Ltd., Siemens Medical Solutions USA, Inc., and IBA.

Market Segment:

Medical Cyclotron Product Outlook (Revenue, USD Million, Volume Units, 2014 - 2025)
    • Cyclotron 10-12 MeV
    • Cyclotron 16-18 MeV
    • Cyclotron 19-24 MeV
    • Cyclotron 24 MeV & above

Medical Cyclotron Regional Outlook (Revenue, USD Million, Volume Units, 2014 - 2025)
    • North America
        • U.S.
        • Canada
    • Europe
        • Germany
        • U.K.
    • the Asia Pacific
        • Japan
        • Australia
    • Latin America
        • Brazil
        • Mexico
    • Middle East & Africa
        • South Africa